跳至主要内容
临床试验/NCT07191054
NCT07191054撤回不适用

Prospective Trial Of Patient Outcomes and PALS Sepsis Guideline Adherence In Patients Fluid Resuscitated With The LifeFlow® Rapid Infuser Compared To Traditional Methods

Phoenix Children's Hospital2 个研究点 分布在 1 个国家开始时间: 2019年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Time to third bolus completion

研究概览

简要总结

This is a prospective, comparative, blinded, randomized study to prove the safety, efficacy and ease of use of the LifeFlow® device in pediatric patients presenting to an emergency department with concern for sepsis. This study will include 600 patients, 300 will receive the LifeFlow® device to deliver intravenous fluids while another 300 patients will receive the conventional push/pull method.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
1 Year 至 19 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Less than 19 years old
  • Trigger the Best Practice Alert in triage
  • Treating physician elects to do the full sepsis bundle.

排除标准

  • Less than 20kg in weight
  • Patients on diuretics for cardiac or renal conditions
  • Patients who cannot communicate in either English or Spanish

结局指标

主要结局

Time to third bolus completion

时间窗: 60 Minutes

Time To first bolus completion

时间窗: 20 Minutes

Time to hospital admission

时间窗: 24 hours

Time from presentation to the ER until admission to the hospital

Nursing satisfaction

时间窗: 1 day

Likert scale of satisfaction with style of fluid administration used. From not satisfied to extremely satisfied.

次要结局

  • Hospital Length of Stay(Days)
  • ICU days(Days)
  • Vasoactive medication use(1 day)
  • Morbidity and Mortality(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

LifeFlow Sepsis Study | 临床试验